S-1 registration
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
Sector: In Vitro & In Vivo Diagnostic SubstancesIndustry: Medical - DevicesCountry: USExchange: NYSE
DilutionScan read 48 of VOLITIONRX LTD's SEC filings and found 20 warrant series, 2 convertibles, 2 ATM programs, 7 shelf registrations, 1 S-1 registration and 4 completed offerings on file for VNRX. The latest dilution event on file is a note conversion on Sep 23, 2026. Analysis updated Oct 27, 2026.
Raise routes on file: active ATM + effective shelf + effective S-1 · latest dilution event 41 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Sep 23, 2026 · Note Conversion
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2025
Proposed maximum
Shares registered
Shares Underlying
Exercise Price
Issued 2025
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Principal
Conversion Price
Principal
Conversion Price
Issued 2025
Total capacity
Sold to date
Issued 2022
Total capacity
Sold to date
Issued 2024
Total capacity
Remaining
Issued 2021
Total capacity
Remaining
Issued 2026
Total capacity
Remaining
Issued 2026
Total capacity
Remaining
Issued 2026
Total capacity
Remaining
Issued 2025
Total capacity
Remaining
Issued 2025
Gross proceeds
Price per share
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Medical - Devices. All tickers A to Z